These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4448525)

  • 1. Compatibility of oral contraceptive with anti-tubercular chemotherapy in female pulmonary tuberculosis patients.
    Mehrotra ML; Gautam KD; Pande DC; Chaube CK; Dixit R; Malhotra A; Kushwaha S
    Indian J Med Res; 1974 Nov; 62(11):1782-6. PubMed ID: 4448525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
    Gidwani GP; Purandare BN
    J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats.
    Zaki K; Sami GE; Wassef SA; Nour H; Hassan AA
    Egypt Popul Fam Plann Rev; 1973 Jun; 6(1):33-50. PubMed ID: 12257875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some observations on the changes in capillary resistance in oral contraceptive users.
    Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological and histochemical changes in the cervix uteri under contraceptive pills.
    El Hakim SM; Abdin FH; Kandil O
    Egypt Popul Fam Plann Rev; 1976 Dec; 10(2):20-33. PubMed ID: 12308408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some aspects of studies with oral contraceptives in Indian women.
    Shah PN
    J Obstet Gynaecol India; 1966 Aug; 16(4):409-14. PubMed ID: 12262163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver function tests in women using oral contraceptive.
    Gupta P; Sharma PA
    J Obstet Gynaecol India; 1972; 22(5):562-6. PubMed ID: 12332882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infarction of the midgut associated with oral contraceptives. Report of two cases.
    Brennan MF; Clarke AM; Macbeth WA
    N Engl J Med; 1968 Nov; 279(22):1213-4. PubMed ID: 5687397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological changes in the ovary under the effect of oral contraceptive.
    Achari K
    J Obstet Gynaecol India; 1969 Dec; 19():737-40. PubMed ID: 12254872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical aspects of Ovulen application as a contraceptive and in gynecological disorders].
    Bulska M; Sternadel Z; Pietrusiewicz W
    Ginekol Pol; 1970; 41(8):877-82. PubMed ID: 5459598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenteric venous thrombosis associated with oral contraceptives: a case report.
    Milne PY; Thomas RJ
    Aust N Z J Surg; 1976 May; 46(2):134-6. PubMed ID: 1067070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of blood coagulation parameters.
    Newman RL; Sirridge M; Brinkman M; Shannon R
    Am J Obstet Gynecol; 1976 May; 125(1):108-14. PubMed ID: 775991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.